A levodopa-encapsulated poly-ε-caprolactone nanocomposite lmproves the motor symptoms and neurochemical changes in a rotenone-induced mouse model of parkinson’s disease
JavaScript is disabled for your browser. Some features of this site may not work without it.
A levodopa-encapsulated poly-ε-caprolactone nanocomposite lmproves the motor symptoms and neurochemical changes in a rotenone-induced mouse model of parkinson’s disease